United States · FDA National Drug Code directory
OXCARBAZEPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70377-117_f99a88aa-8790-c34c-72d2-aa7a7dec80af
- Product NDC
- 70377-117
- Form
- SUSPENSION
- Composition / generic term
- OXCARBAZEPINE
- Labeler
- Biocon Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240531
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 60 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (70377-117-11) / 250 mL in 1 BOTTLE · 70377-117-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →